Skip to main content
. 2018 Mar;59(3):434–441. doi: 10.2967/jnumed.117.202945

FIGURE 5.

FIGURE 5.

68Ga-PSMA-11 PET/CT scan in 70-y-old man with BCR (PSA level, 1.06 ng/mL; doubling time, 7 mo) of initially high-risk prostate cancer (Gleason score, 8; pT2c) 1 y after primary radical prostatectomy. Intended treatment before 68Ga-PSMA-11 PET/CT was active surveillance (Q1). 68Ga-PSMA-11 PET/CT showed intense 68Ga-PSMA-11 uptake (SUVmax, 10.8) in 4-mm right internal iliac pelvic lymph node (yellow arrows). Intended treatment after 68Ga-PSMA-11 PET/CT (Q2) was surgery, which was implemented. Patient underwent pelvic lymph node dissection 2 mo later, which confirmed metastatic prostatic adenocarcinoma. (A) 68Ga-PSMA-11 PET maximum-intensity projection. (B) Axial CT. (C) Axial 68Ga-PSMA-11 PET/CT.